EGFR and lung carcinoma: Otherwise, the prevalence of somatic mutations in other commonly mutated cancer genes in Asian lung cancer patients including EGFR (44.6% (41/92) in patients with germline mutations vs. 46.7% (675/1434) in patients without, p = 0.720) was comparable in patients with P/LP germline mutations and those without.